Useful links
Regulatory issues
European Union
Significant changes in European law governing clinical trials came into effect on 1st May 2004. The main aim of the Directive - The Medicines for Human Use (clinical trials) Regulations 2004 - is to simplify the administrative processes governing clinical trials and therefore establish a harmonised procedure for clinical trials throughout the European Community.
To find out more about what this new Directive means in the UK, please click here.
ADAllen Pharma is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) to wholesale pharmaceuticals.
United States of America
Clinical trials in the USA are regulated by the Center for Drug Evaluation and Research within the Food and Drug Administration (FDA).
Click here to find out more about the regulations governing trials in the USA.